Hot Topics Discussed in Covance Spring Webinars

Unlock opportunities for your clinical research programs and deliver results that Covance Spring Webinars Video Nash Diabetic Heart Biomarkersmatter.
We’re excited to be on the cutting edge of drug development solutions. Take a look at past and future webinar topics and leverage our experience.

Rare and Orphan Diseases Patient Perceptions Implications for Recruitment, Retention and Compliance in Clinical Trials

Do you face the challenge of recruiting and retaining rare disease patients for orphan drug clinical trials? Now, discover how you can boost participation, enhance outcomes and speed drug development in this competitive market. Join Dr. Rolando Gutierrez-Esteinou, MD, Vice President, Therapeutic Area Head, Neuroscience Medical and Scientific Services at Covance, for this timely Webinar.

May 4, 11 a.m. EDT | Register now


Implementing Basket/Bucket and Umbrella Designs: What You Need to Know for Global Oncology Trials

Recent successes in the treatment of cancer have led to more complex trials. Join our experts to learn more about the challenges faced in executing oncology trials and gain new insights on how to optimize your backet/bucket and umbrella designs.

May 8, 11 a.m. EDT | Register now

Biomarkers and Immuno-oncology: Identifying New Opportunities for Precision Medicine

Predictive and pharmacodynamics biomarkers are a critical component of today’s process in immuno-oncology drug development.  Join us for this informative webinar to learn about the latest issues in biomarker development and explore the critical junction between pharmaceutical companies, companion diagnostic manufacturers and CROs to enable an effective co-development process.

May 17, 11 a.m. EDT | Register now

Evidence-Based Approaches for Accelerating Patient Enrollment in Oncology

The number of oncology clinical trials has increased exponentially in recent years, putting ever more pressure on increasing clinical trial efficiency by reducing costs and timelines. Discover proven solutions for overcoming the enormous challenge of study planning and patient recruitment from two key experts.

May 24, 11 a.m. EDT | Register now

Phase I cGMP Drug Manufacturing at the CRU: 3 Key Benefits

Drug manufacturing can make up to 40 percent of the total cost to develop a new chemical entity and can be an inflexible, time consuming and frustrating experience during your first-in-human clinical trial. But it doesn’t have to when you use a cGMP pharmacy at your clinical research unit (CRU) for Phase I drug manufacturing. Our approach yields benefits in quality and safety, timeline reduction and cost efficiency.

June 6, 11 a.m. EDT | Register now



Choosing the Right Fit For Your Functional Provision Service Model

Many sponsors are turning toward a Functional Service Provision Model to lower overhead and enable greater efficiencies. Listen to two of our experts provide key outsourcing strategies in this informative webinar recording. > View webinar now 

The Diabetic Heart: A Focus on Heart Failure 

Hear an insightful discussion on how certain molecular classes impact CV outcomes for patients with type 2 diabetes along with strategies for testing new therapeutic, paradigm-modifying treatment modalities. > View webinar now

Hot Topics in Non-Alcoholic Steatohepatitis (NASH) 

In this webinar, experts discuss:

1) Genetic predisposition and other risk factors for disease progression
2) How to assess and monitor drug-induced liver injury (DILI) in patients.
3) Strategic and statistical considerations for seamless adaptive design in NASH trials.> View webinar now

The Biosimilars Landscape: Key Pieces of the Puzzle for Clinical and Commercial Success: 2017-2021 – What all developers need to know

The regulatory pathway for developing biosimilars in the U.S. is still considered a new frontier. View this webinar as we discuss the key clinical issues sponsors face when navigating today’s regulatory environment. > View webinar now

Turning Biorepositories into Translational Science Treasure Troves: The Value of Uniquely Complete Data Sets

As clinical trials incorporate wider patient populations around the globe and the number of biomarker assays available increases, your specimen biorepositories represent an increasingly valuable resource for translational science. Learn how to get more value from your biorepository specimens by transcending data silos and gaining pan-pipeline insights to help you bring fresh approaches to your research. > View webinar now